Usha Sharma – Mumbai
More than 900 exhibitors and over 26,000 delegates from 21 countries participated in the CPhI India event to make it a huge success. The event was recently held in India’s business capital Mumbai at the Bombay Exhibition Centre (BEC) from November 21-23, 2012. This year’s event saw large number of international visitors and evinced satisfactory responses from the exhibitors.
Rajeev Kher, Additional Secretary, Ministry of Commerce and Industry inaugurated the show along with Dr PV Appaji, Director General, Pharmexcil, NR Munjal, Chairman, Pharmexcil, and Sanjeev Kher, Managing Director, UBM.
Making his rounds of the various exhibitor halls and spending time with key exhibitors like ACG Worldwide, Shimadzu Analytical, Signet Chemicals, Calyx Chemicals and the like, Kher spoke about the Commerce Ministry’s plans to support all segments of the industry.
Speaking on the sidelines of the meet, Kher said, “Our overall target exports for this financial year is $320 billion and to ensure that we reach this in the remaining five months, we are reviewing our position and strategy. One of these strategies is to diversify into different geographies. We are working on breaking into markets other than the US and EU like Africa, China, CIS countries, Russia, the Middle East and North America.”
He also mentioned that besides additional markets, the Ministry is also considering other measures like special incentives and more market promotional activities to boost pharma exports.
He continued, “By the end of 2014-15, India’s pharma exports are expected to reach $25 billion. The Indian pharma industry is also covering a lot of ground in biopharmaceuticals at a rapid pace. Simultaneously, the global generic market segment is growing faster than the branded drugs. The market size of drugs losing patent protection was $270 billion in 2011 and is expected to go up to $430 billion by 2016. Therefore, it is but natural to view the Indian pharma industry at the top in the next decade.
One of the major market promotional activities is the ‘Brand India Pharma’ campaign, a major branding initiative highlighting the three key proven characteristics of Indian pharma: presence across 230 countries, accessibility due to affordable pricing and high quality.
Kher emphasised that the Ministry of Commerce will fully support Pharmexcil in its efforts to take the ‘Brand India Pharma campaign’, symbolised by a stylised Rx, to all countries and geographies.
He further emphasised that the domestic pharma industry is gearing up in a big way, with more and more people likely to be covered by various health benefit policies, be it insurance and with facilities offered by the healthcare industry matching the best in the world.
This year’s show had visitors from across the globe, who had pre-registered for the three-day exhibition, which was held in seven exhibition halls spread over 55,000 sq. mt. P-MEC India had 45 new exhibiting companies and several new features like a new mobile app for easy real time navigation of the exhibition halls.
A series of technical seminars, presented by exhibitors, were held throughout the event. A CEO conclave with a panel discussion was held at the Westin Hotel, Goregaon, followed by the unveiling of the first CPhI India Pharma Awards.
| The event provided an efficient platform for global pharma buyers to identify business opportunities and meet with potential partners. Check out what the exhibitors had to say about the event |
|
– Suresh Pareek, Managing Director, Ideal Cures – Sandeep Bijamwar, Business Head-Healthcare API Advanced Enzymes – Gergory D’souza, Managing Director, Anchor Mark Healthcare – S M J Noronha, President & CEO, ACG Worldwide – Vishal Wagh, Director—Marketing, Adam Fabrick – S M Rabee, Director, Bowman & Archer Pharma Machine India It was a good event, with better customer quality. We sold one high speed capsule filling machine to Cipla during the event. – Suhas Rai, Country Head-Sales, Bosch |
Next year, the event will held at the same venue, from December 3-5, 2013.